Cargando…
Infarct size and long-term left ventricular remodelling in acute myocardial infarction patients subjected to transcoronary delivery of progenitor cells
INTRODUCTION: Infarct size (IS) is a fundamental determinant of left-ventricular (LV) remodelling (end-systolic and end-diastolic volume change, ΔESV, ΔEDV) and adverse clinical outcomes after myocardial infarction (MI). Our prior work found that myocardial uptake of transcoronary-delivered progenit...
Autores principales: | Czyż, Łukasz, Tekieli, Łukasz, Miszalski-Jamka, Tomasz, Banyś, R. Paweł, Szot, Wojciech, Mazur, Wojciech, Chmiel, Jakub, Mazurek, Adam, Skubera, Maciej, Dąbrowski, Władysław, Jarocha, Danuta, Podolec, Piotr, Majka, Marcin, Musiałek, Piotr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10031670/ https://www.ncbi.nlm.nih.gov/pubmed/36967855 http://dx.doi.org/10.5114/aic.2023.125079 |
Ejemplares similares
-
Transcoronary stem cell transfer and evolution of infarct-related artery atherosclerosis: evaluation with conventional and novel imaging techniques including Quantitative Virtual Histology (qVH)
por: Dabrowski, Wladyslaw, et al.
Publicado: (2023) -
Myocardial regeneration strategy using Wharton's jelly mesenchymal stem cells as an off-the-shelf ‘unlimited’ therapeutic agent: results from the Acute Myocardial Infarction First-in-Man Study
por: Musialek, Piotr, et al.
Publicado: (2015) -
Single-photon emission computed tomography as a fundamental tool in evaluation of myocardial reparation and regeneration therapies
por: Tekieli, Łukasz, et al.
Publicado: (2023) -
Randomized transcoronary delivery of CD34(+) cells with perfusion versus stop-flow method in patients with recent myocardial infarction: Early cardiac retention of (99m)Tc-labeled cells activity
por: Musialek, Piotr, et al.
Publicado: (2010) -
Multi-modality imaging in the CIRCULATE-AMI pilot study cohort: a framework for an imaging-based randomized controlled trial of Wharton jelly mesenchymal stem cell use to stimulate myocardial repair/regeneration
por: Drabik, Leszek, et al.
Publicado: (2023)